Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 7417 results
Advanced filters: Author: Daniel Fisher Clear advanced filters
  • Native top-down proteomics reveals epidermal growth factor receptor–estrogen receptor-alpha (EGFR–ER) signaling crosstalk in breast cancer cells and dissociation of nuclear transport factor 2 (NUTF2) dimers to modulate ER signaling and cell growth.

    • Fabio P. Gomes
    • Kenneth R. Durbin
    • John R. Yates III
    Research
    Nature Chemical Biology
    Volume: 21, P: 1205-1213
  • Here, the authors conduct a metagenomic-based study of England’s rivers to show that biofilm bacteria are taxonomically and functionally diverse and are key to biogeochemical cycling, highlighting the importance of river biofilm bacteria in understanding and monitoring freshwater ecosystem health.

    • Amy C. Thorpe
    • Susheel Bhanu Busi
    • Daniel S. Read
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-14
  • The role of normally silenced transposable elements (TEs) in tumorigenesis remains unclear. Here, the authors show that increased expression of TEs in both patients and mice with colitis or by DNA hypomethylating drugs elicits a viral mimicry response that suppresses tumorigenesis. This viral mimicry response inhibits the stemness of cancer initiating cells in a cell autonomous manner.

    • Frederikke Larsen
    • Will Jeong
    • Samuel Asfaha
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-17
  • Here the authors compare genetic testing strategies in rare movement disorders, improve diagnostic yield with genome analysis, and establish CD99L2 as an X-linked spastic ataxia gene, showing that CD99L2–CAPN1 signaling disruption likely drives neurodegeneration.

    • Benita Menden
    • Rana D. Incebacak Eltemur
    • Tobias B. Haack
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-21
  • The authors find that distinct radial glia subtypes generate and support midbrain dopaminergic neurons, revealing specialized function and lineage relationships among the diverse cell types that shape dopamine neuron development.

    • Emilía Sif Ásgrímsdóttir
    • Luca Fusar Bassini
    • Ernest Arenas
    ResearchOpen Access
    Nature Neuroscience
    P: 1-15
  • Neville, Ferguson et al. show that non-canonical Polycomb repressive complex 1.1-mediated gene silencing is antagonized by DOT1L and is required for the therapeutic efficacy of Menin and DOT1L inhibitors in mixed-lineage leukaemia.

    • Daniel Neville
    • Daniel T. Ferguson
    • Omer Gilan
    ResearchOpen Access
    Nature Cell Biology
    Volume: 28, P: 307-322
  • Integrated single-cell and spatial data analysis, combined with bidirectional CRISPR screens, identify the transcription factor GLIS3 as a key driver of chronic inflammation and fibrosis and a potential marker of disease severity in patients with ulcerative colitis.

    • Vladislav Pokatayev
    • Alok Jaiswal
    • Ramnik J. Xavier
    ResearchOpen Access
    Nature
    P: 1-10
  • Scholl et al. show that PopZ forms filamentous condensates driven by its helical domain and inhibited by its disordered region. Phase-dependent conformations modulate client interactions and disruption of filamentation or condensation impairs cellular function and growth.

    • Daniel Scholl
    • Tumara Boyd
    • Keren Lasker
    ResearchOpen Access
    Nature Structural & Molecular Biology
    P: 1-13
  • KRAS mutations are keenly associated with pancreatic ductal adenocarcinoma and represent a potential therapeutic target. Here the authors present the findings from a phase I clinical trial testing pooled KRAS mutant peptides in combination with immune checkpoint blockade in patients with resected pancreatic ductal adenocarcinoma.

    • Amanda L. Huff
    • S. Daniel Haldar
    • Neeha Zaidi
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-18
  • Taveneau et al. leverage artificial-intelligence-driven protein design to create inhibitors that control RNA-targeting enzymes in cells, revealing a strategy to rapidly design off-switches for RNA-editing systems.

    • Cyntia Taveneau
    • Her Xiang Chai
    • Gavin J. Knott
    ResearchOpen Access
    Nature Chemical Biology
    P: 1-9
  • In targeted protein degradation, a degrader molecule brings a neosubstrate protein proximal to a hijacked E3 ligase for its ubiquitination. Here, pseudo-natural products derived from (−)-myrtanol—iDegs—are identified to inhibit and induce degradation of the immunomodulatory enzyme indoleamine-2,3-dioxygenase 1 (IDO1) by a distinct mechanism. iDegs prime apo-IDO1 ubiquitination and subsequent degradation using its native proteolytic pathway.

    • Elisabeth Hennes
    • Belén Lucas
    • Herbert Waldmann
    ResearchOpen Access
    Nature Chemistry
    P: 1-12
  • González-Gualda, Reinius et al. demonstrate that platinum-based chemotherapy-induced senescence promotes malignancy in ovarian and lung cancer via TGFβ ligands, with evidence in mouse models validated in clinical samples. Concomitantly blocking TGFβ signaling with chemotherapy reduces tumor burden and increases survival in mice.

    • Estela González-Gualda
    • Marika A. V. Reinius
    • Daniel Muñoz-Espín
    ResearchOpen Access
    Nature Aging
    Volume: 6, P: 368-392
  • Risk associated with genetically defined forms of autism spectrum disorder (ASD) can propagate by means of transcriptional regulation to affect convergently dysregulated pathways, providing insight into the convergent impact of ASD genetic risk on human neurodevelopment.

    • Aaron Gordon
    • Se-Jin Yoon
    • Daniel H. Geschwind
    ResearchOpen Access
    Nature
    P: 1-13
  • Mass spectrometry (MS)-based proteomics is increasingly central to systems biology. Here, the authors present a high-throughput, multi-organ workflow that profiles 11,472 proteins in 507 mouse samples, enabling rapid, system-level evaluation of drug efficacy and toxicity.

    • Yun Xiong
    • Lin Tan
    • Philip L. Lorenzi
    ResearchOpen Access
    Nature Communications
    P: 1-17
  • Natural products inspire the development of pseudo-natural products through combinations of fragments of compound classes that are chemically and biologically distinct. Here, the authors report a library of 244 pseudo-natural products, evaluate them in the cell painting essays and identify the phenotypic role of individual fragments.

    • Michael Grigalunas
    • Annina Burhop
    • Herbert Waldmann
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-11
  • APOBEC deaminases restrict retroviruses but can also mutate human DNA. Here, the authors show that cancerassociated APOBEC3s with low RNA binding, known to enter the nucleus, are selectively recognized by E3 ligases and degraded, eliminating harmful nuclear enzymes, and limiting genome mutation.

    • Irene Schwartz
    • Valentina Budroni
    • Gijs A. Versteeg
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-24
  • Using two newly developed immunoassays tested in three clinical cohorts, this study highlights CSF DOPA decarboxylase as a promising biomarker for differentiating dementia with Lewy bodies and Parkinson’s disease from Alzheimer’s disease and controls.

    • Katharina Bolsewig
    • Giovanni Bellomo
    • Charlotte E. Teunissen
    ResearchOpen Access
    Nature Medicine
    P: 1-12
  • Hepatic glycogenolysis is essential for protein glycosylation and rhythmic secretion by the liver. Disruptions to hepatic glycogenolysis, caused by congenital diseases or physiological factors such as obesity, caloric restriction and changes to meal timing, alter hepatic protein secretion.

    • Meltem Weger
    • Daniel Mauvoisin
    • Frédéric Gachon
    ResearchOpen Access
    Nature Metabolism
    P: 1-23
  • Rare loss-of-function mutations in SETD1A are associated with schizophrenia, but how SETD1A haploinsufficiency leads to disease phenotypes remains unknown. Here, authors show that SETD1A regulates genes at common schizophrenia risk loci regulating genomic stability and synaptic function.

    • Tomoyo Sawada
    • Arthur S. Feltrin
    • Jennifer A. Erwin
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-20
  • WIN332 is an HIV-1 Env protein designed to elicit a new class of Asn332-glycan-independent antibodies (type II) to the V3-glycan site of Env. WIN332 immunization rapidly induces type-II V3-glycan antibodies with low inhibitory activity indicative of a neutralization activity in macaques.

    • Ignacio Relano-Rodriguez
    • Jianqiu Du
    • Amelia Escolano
    ResearchOpen Access
    Nature Immunology
    P: 1-14
  • In a phase 2 trial evaluating healthy donor fecal microbial transplantation plus either anti-PD-1 in patients with non-small cell lung cancer or anti-PD-1 and anti-CTLA-4 in patients with melanoma, encouraging efficacy was seen in both cohorts, with responses linked to significantly greater loss of baseline bacterial species.

    • Sreya Duttagupta
    • Meriem Messaoudene
    • Arielle Elkrief
    ResearchOpen Access
    Nature Medicine
    P: 1-14
  • The systemic discovery of metal–small-molecule complexes from biological samples is a difficult challenge. Now, a method based on liquid chromatography and native electrospray ionization mass spectrometry has been developed. The approach uses post-column pH adjustment and metal infusion combined with ion identity molecular networking, and a rule-based informatics workflow, to interrogate small-molecule–metal binding.

    • Allegra T. Aron
    • Daniel Petras
    • Pieter C. Dorrestein
    Research
    Nature Chemistry
    Volume: 14, P: 100-109
  • Analysis of a placebo-controlled trial of a BCMA-targeting CAR-T cell therapy in patients with myasthenia gravis shows that CAR-T cell infusion selectively remodels the systemic immune environment, with elimination of BCMA-high plasma cells and activated plasmacytoid dendritic cells and changes in the autoreactive B cell repertoire.

    • Renee R. Fedak
    • Rachel N. Ruggerie
    • Kelly Gwathmey
    ResearchOpen Access
    Nature Medicine
    P: 1-13
  • Human immunodeficiency virus (HIV)-associated gut microbiome dysbiosis correlates with systemic immunodeficiency and opportunistic gut infections. Faecal microbiome transplantation from people living with HIV with high peripheral CD4+ T cell counts improved intestinal immunity and protection against Cryptosporidium parvum in mice.

    • Stavros Bashiardes
    • Melina Heinemann
    • Eran Elinav
    Research
    Nature Microbiology
    P: 1-14
  • Despite high morbidity and mortality, there are currently no approved vaccines for protection against Middle East respiratory syndrome (MERS) coronavirus. Here the authors develop a ferritin nanoparticle-based MERS-CoV vaccine that elicits high levels of neutralizing antibodies in mice, non-human primates, and alpacas and prevents infection in an alpaca challenge model.

    • Abigail E. Powell
    • Hannah Caruso
    • Brad A. Palanski
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-22
  • A platform using matched patient-derived lung tumouroids and healthy lung organoids enables accurate examination of patient responses to CAR T therapy and offers a faithful framework for improved CAR T design.

    • Lukas Ehlen
    • Martí Farrera-Sal
    • Michael Schmueck-Henneresse
    ResearchOpen Access
    Nature Biomedical Engineering
    P: 1-17
  • Becker et. al developed a proteomic proximity labeling platform named POCA, which makes use of a photosensitizer for singlet oxygen production and protein capture in the presence of amine, enabling profiling of interactomes of proteins and lipids in living cells.

    • Andrew P. Becker
    • Elijah Biletch
    • Keriann M. Backus
    Research
    Nature Chemical Biology
    P: 1-11
  • In this article, the authors characterise genetic variation in CARTaGENE, a population-based cohort from Quebec, Canada. This genomic resource enables population and disease genetic studies in a founder population and other under-represented groups.

    • Peyton McClelland
    • Georgette Femerling
    • Guillaume Lettre
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-17
  • How the brain supports speaking and listening during conversation of its natural form remains poorly understood. Here, by combining intracranial EEG recordings with Natural Language Processing, the authors show broadly distributed frontotemporal neural signals that encode context-dependent linguistic information during both speaking and listening..

    • Jing Cai
    • Alex E. Hadjinicolaou
    • Sydney S. Cash
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-13
  • Bioactivity-guided isolation of specialized metabolites is an iterative process. Here, the authors demonstrate a native metabolomics approach that allows for fast screening of complex metabolite extracts against a protein of interest and simultaneous structure annotation.

    • Raphael Reher
    • Allegra T. Aron
    • Daniel Petras
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-12
  • Ramaglia and colleagues show that aberrant formation of B cell-rich lymphoid structures in the brain meninges is associated with high CXCL13:BAFF ratios. Inhibiting the kinase BTK reduces the lymphotoxin signaling needed to sustain such structures, lowers CXCL13:BAFF ratios and reduces cortical tissue injury.

    • Ikbel Naouar
    • Andrei Pangan
    • Valeria Ramaglia
    Research
    Nature Immunology
    Volume: 27, P: 48-60
  • Barcoding aids in the optimization of lipid nanoparticles. Here, the authors report on multiplexed mRNA barcoding that enables high-resolution spatiotemporal profiling of lipid nanoparticles, linking accumulation kinetics to functional delivery and revealing zonal liver targeting.

    • Stephen T. Moore
    • Xizhen Lian
    • Daniel J. Siegwart
    ResearchOpen Access
    Nature Communications
    Volume: 17, P: 1-13
  • A comprehensive atlas platform integrating transcriptional and epigenetic data enables more precise engineering of T cell states, accelerating the rational design of more effective cellular immunotherapies.

    • H. Kay Chung
    • Cong Liu
    • Wei Wang
    ResearchOpen Access
    Nature
    P: 1-11